The role of stem cells in atherosclerosis.
Accumulating evidence indicates the involvement of stem cells and/or progenitors in the development of arteriosclerosis, including transplant arteriosclerosis, angioplasty-induced restenosis, vein graft atherosclerosis and spontaneous atherosclerosis. Recently, it was demonstrated that stem/progenitor cells existing in the circulation and adventitia contribute to endothelial repair and smooth muscle cell (SMC) accumulation. Atherosclerosis can be initiated by endothelial death in specific areas, e.g. bifurcation regions, and subsequent replacement by stem/progenitor cells. Meanwhile, progenitor cells from blood and the adventitia migrate into the intima where they proliferate and differentiate into neo-SMC. Stem/progenitor cells are responsible for the formation of atherosclerotic lesions, which appear as an inflammatory disease. Thus, these cells may be a source of endothelial cells and SMC, and might have implications for cellular, genetic, and tissue engineering approaches to vascular disease.
Xu
Q
Q
Department of Cardiac and Vascular Sciences, St George's Hospital Medical School, London, UK. q.xu@sghms.ac.uk
D001161:Arteriosclerosis / Q000503:physiopathology*; D002454:Cell Differentiation; D049109:Cell Proliferation; D023903:Coronary Restenosis / Q000503:physiopathology; D042783:Endothelial Cells; D006801:Humans; D007249:Inflammation; D009130:Muscle, Smooth / Q000166:cytology*; D013234:Stem Cells / Q000502:physiology*; D023822:Tissue Engineering